Shared on27 Sep 25Fair value Increased 3.54%
Analysts have raised their price target for Ayvens to €11.27, citing stronger-than-expected financial performance, improved growth prospects, and greater earnings visibility, while some like JPMorgan remain cautious despite this upward revision. Analyst Commentary Bullish analysts cite improving fundamentals and upgraded growth outlook as rationale for raising their rating.
Shared on23 Apr 25Fair value Increased 6.50%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 0.44%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 0.66%
AnalystConsensusTarget has increased revenue growth from 3.2% to 4.1%.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Decreased 8.91%
AnalystConsensusTarget has decreased revenue growth from 4.1% to 3.2%, decreased future PE multiple from 8.2x to 7.1x and decreased shares outstanding growth rate from 0.0% to -0.0%.